Guochun Liao brings over 15 years of experience leading and managing multi-discipline teams in large pharmaceutical and small biotechnology startup companies. Prior to founding IDbyDNA, he was the Vice President of Bioinformatics at Centrillion Biosciences. Before that, he was the Head of Computational Genomics and Research Biostatistics at Roche Pharmaceuticals Palo Alto site, where he was responsible for the data management and analysis for the pre-clinical and clinical projects covering a variety of disease biology and functional areas. Guochun has also served as a consulting professor at Stanford University School of Medicine. His scientific work is featured in many patents, peer reviewed publications and on the cover of scientific journals, including Science and Genome Research. Guochun holds a BS in Biophysics from the University of Science and Technology of China, and an MS in Computer Science, a Ph.D. in Genetics and an MBA from the University of California, Berkeley.
Robert Schlaberg is an Assistant Professor of Pathology at the University of Utah School of Medicine and a Medical Director at ARUP Laboratories. His research is focused on next-generation sequencing-based infectious disease diagnostics and is supported in part by the Bill & Melinda Gates Foundation. Robert co-developed Taxonomer, the metagenomics data analysis platform, utilized by IDbyDNA as its central technology. Robert received Medical degrees from the Julius-Maximilians-University in Wuerzburg, Germany and a Masters of Public Health from Columbia University where he also trained in clinical pathology and served as Chief Clinical Pathology Resident. Robert is a board certified Clinical Pathologist and Medical Microbiologist.
Mark Yandell is a recognized leader in the field of software development for comparative and functional genomics. He is a Professor of Human Genetics and H.A. & Edna Benning Presidential Endowed Chair at the University of Utah, serves as Director of the Bioinformatics program, and Co-director of the Utah Science Technology and Research Center for Genetic Discovery. In addition to developing essential algorithms for the Human Genome Project, Mark developed software at Celera Genomics used to analyze human, mouse, fruit fly, and mosquito genomes. Mark also serves as Technical Director of the Utah Genome Project, and Associate Director of the University of Utah Program in Personalized Health. Mark holds a PhD in Molecular, Cell & Developmental Biology from The University of Colorado, Boulder and completed his post-doctoral work in Computational Biology at Washington University, St. Louis.
Jeff Field brings more than 20 years of commercial leadership experience spanning the biotech, pharmaceutical, managed care, molecular diagnostics, and genetics/genomics industries. Jeff joins IDbyDNA from GenePeeks, where he served as Chief Commercial Officer. Prior to his role at GenePeeks, Jeff was the Vice President of Sales and Client Services at Foundation Medicine, where he played an instrumental role in developing the company’s commercial strategy and executing the tactical launch plan for its comprehensive tumor genomic profiling services. Before joining Foundation Medicine, Jeff held several executive level positions at Caris Life Sciences including Regional Vice President of Sales, Vice President of Oncology National Accounts, and Vice President of Strategic and Corporate Accounts where he was responsible for sales, payer relations, business development, and contracting activities. In addition, Jeff has helped to build several other disruptive, high-growth companies, including Astra Merck (now AstraZeneca) and AdvancePCS (now CVS Health). Jeff holds an MBA from Rollins College, an MS in Organic/Medicinal Chemistry from Boston College, and a BS in Chemistry from Merrimack College.
Amy Davis has over 12 years of program management and research development experience in life sciences. She joins IDbyDNA from BioFire Diagnostics, a bioMérieux company focused on syndromic infectious disease diagnostics, where she was a program director over new product development and product sustainment programs. Prior to BioFire, Amy directed the University of Utah Health Sciences Research Unit, where she led research development for interdepartmental research initiatives. Amy holds a PhD in Biology from the University of Utah, and she completed postdoctoral training at the University of Colorado Boulder.
Dina Hannah is a Quality and Compliance professional with over 30 years in the clinical reference laboratory and biotech industries. Her experience includes leading corporate compliance, quality systems, corporate privacy, and information security teams in revolutionary and rapidly evolving regulatory and quality system environments. Prior to joining IDbyDNA, she served as Chief Compliance Officer for TriCore Reference Laboratories and as VP, Compliance and Quality for ARUP Laboratories. She began her laboratory sciences career as a certified medical technologist and specialist in blood banking and has nearly 20 years of laboratory compliance experience. Dina received an MBA with an emphasis in health care management from University of Phoenix, a BS in Clinical Laboratory Science from Brigham Young University and is a certified security and information privacy professional.
Qing Li brings over 20 years of management, product leadership, business development and engineering experience in the biotech and software industries. He joins IDbyDNA from Centrillion Biosciences, where he was the Senior Director of Product Marketing, responsible for consumer genomics and bioinformatics products. He was the VP of Products at Trooval.com, a VC backed consumer internet software company. He was the Director of Business Development at Kapow Software, responsible for strategic alliances and channel sales. Previously he held management and engineering positions within leading Silicon Valley companies such as Oracle and TIBCO. He’s an expert in SaaS, Cloud Computing, Enterprise Software, Mobile and Voice Applications, Big Data Analytics and Consumer Genomics. He holds an MBA from the University of California at Berkeley and a BS in Computer Science from Zhejiang University, and attended a PhD program in Computer Science at the University of California, Santa Barbara.
Chris Minunni brings over 10 years of legal, finance, and operations experience working with technology and life science companies in the Bay Area. He joins IDbyDNA from Bracket Computing, a venture-backed enterprise infrastructure and security software company, where he was Vice President of Business Operations and General Counsel. Previously he was a corporate attorney at Cooley LLP. He holds a JD from Columbia Law School and a BA from Cornell University.
Jun Wang brings over 19 years of leadership, management and R&D experience from large molecular diagnostics and biotech startup companies. He joins IDbyDNA from Sansure Biotech, a leading molecular diagnostic company in China, where he served as board member and chief technology officer. He also served as a distinguished professor at Central South University. Prior to these, Jun led research groups at Fluidigm Corporation and Roche Molecular Diagnostics. His scientific work is featured in over 50 peer-reviewed scientific publications and patents. Jun holds a PhD of biochemistry from University of Toronto and completed his post-doctoral work at Roche Pharmaceutical Palo Alto site. He also holds a MS in biochemistry from Peking University and BS in biochemistry from Sichuan University.